The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - March 21, 2024 Category: Cancer & Oncology Authors: Ruoyang Li Xuewei Zhao Yunfei Huang Chunxiao Li Lei Liu Meiqi Wang Jiaxing Wang Zhenchuan Song Source Type: research